Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations | ||
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Universite de Lausanne | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte | |
| dc.conicet.organizacion | Comisión Nacional de Energía Atómica. Centro Atómico Bariloche | |
| dc.conicet.organizacion | University Hospital Giessen | |
| dc.conicet.organizacion | Royal Hospital for Children Glasgow | |
| dc.conicet.organizacion | Universidad Complutense de Madrid | |
| dc.conicet.organizacion | University Hospital Carl Gustav Carus | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte | |
| dc.conicet.organizacion | Comisión Nacional de Energía Atómica. Gerencia del área de Seguridad Nuclear y Ambiente. Instituto de Energía y Desarrollo Sustentable. Instituto de Energía y Desarrollo Sustentable - Sede Bariloche | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Universite de Lausanne | |
| dc.conicet.organizacion | Universite de Nantes | |
| dc.conicet.organizacion | University Hospital Halle | |
| dc.conicet.organizacion | Université Paris-Cité, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases | |
| dc.conicet.organizacion | Universitat Ulm | |
| dc.conicet.organizacion | Universitat Ulm | |
| dc.conicet.organizacion | Université Paris-Cité, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.conicet.organizacion | Albert Ludwigs University of Freiburg | |
| dc.contributor.author | Maccari, Maria Elena | |
| dc.contributor.author | Schneider, Pascal | |
| dc.contributor.author | Smulski, Cristian Roberto | |
| dc.contributor.author | Meinhardt, Andrea | |
| dc.contributor.author | Pinto, Fernando | |
| dc.contributor.author | Gonzalez Granado, Luis Ignacio | |
| dc.contributor.author | Schuetz, Catharina | |
| dc.contributor.author | Sica, Mauricio Pablo | |
| dc.contributor.author | Gross, Miriam | |
| dc.contributor.author | Fuchs, Ilka | |
| dc.contributor.author | Kury, Patrick | |
| dc.contributor.author | Heeg, Maximilian | |
| dc.contributor.author | Vocat, Tatjana | |
| dc.contributor.author | Willen, Laure | |
| dc.contributor.author | Thomas, Caroline | |
| dc.contributor.author | Hühn, Regina | |
| dc.contributor.author | Magerus, Aude | |
| dc.contributor.author | Lorenz, Myriam | |
| dc.contributor.author | Schwarz, Klaus | |
| dc.contributor.author | Brieux Olivera, Amelia Carolina Marta | |
| dc.contributor.author | Ehl, Stephan | |
| dc.contributor.author | Rensing Ehl, Anne | |
| dc.date.issued | 2023-01 | |
| dc.description.abstract | Background: Fas ligand (FasL) is expressed by activated T cells and induces death in target cells upon binding to Fas. Loss-of-function FAS or FASLG mutations cause autoimmune-lymphoproliferative syndrome (ALPS) characterized by expanded double-negative T cells (DNT) and elevated serum biomarkers. While most ALPS patients carry heterozygous FAS mutations, FASLG mutations are rare and usually biallelic. Only 2 heterozygous variants were reported, associated with an atypical clinical phenotype. Objective: We revisited the significance of heterozygous FASLG mutations as a cause of ALPS. Methods: Clinical features and biomarkers were analyzed in 24 individuals with homozygous or heterozygous FASLG variants predicted to be deleterious. Cytotoxicity assays were performed with patient T cells and biochemical assays with recombinant FasL. Results: Homozygous FASLG variants abrogated cytotoxicity and resulted in early-onset severe ALPS with elevated DNT, raised vitamin B12, and usually no soluble FasL. In contrast, heterozygous variants affected FasL function by reducing expression, impairing trimerization, or preventing Fas binding. However, they were not associated with elevated DNT and vitamin B12, and they did not affect FasL-mediated cytotoxicity. The dominant-negative effects of previously published variants could not be confirmed. Even Y166C, causing loss of Fas binding with a dominant-negative effect in biochemical assays, did not impair cellular cytotoxicity or cause vitamin B12 and DNT elevation. Conclusion: Heterozygous loss-of-function mutations are better tolerated for FASLG than for FAS, which may explain the low frequency of ALPS-FASLG. | es |
| dc.description.fil | Fil: Maccari, Maria Elena. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Schneider, Pascal. Universite de Lausanne; Suiza | |
| dc.description.fil | Fil: Smulski, Cristian Roberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina. Comisión Nacional de Energía Atómica. Centro Atómico Bariloche; Argentina | |
| dc.description.fil | Fil: Meinhardt, Andrea. University Hospital Giessen; Alemania | |
| dc.description.fil | Fil: Pinto, Fernando. Royal Hospital for Children Glasgow; Reino Unido | |
| dc.description.fil | Fil: Gonzalez Granado, Luis Ignacio. Universidad Complutense de Madrid; España | |
| dc.description.fil | Fil: Schuetz, Catharina. University Hospital Carl Gustav Carus; Alemania | |
| dc.description.fil | Fil: Sica, Mauricio Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina. Comisión Nacional de Energía Atómica. Gerencia del área de Seguridad Nuclear y Ambiente. Instituto de Energía y Desarrollo Sustentable. Instituto de Energía y Desarrollo Sustentable - Sede Bariloche; Argentina | |
| dc.description.fil | Fil: Gross, Miriam. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Fuchs, Ilka. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Kury, Patrick. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Heeg, Maximilian. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Vocat, Tatjana. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Willen, Laure. Universite de Lausanne; Suiza | |
| dc.description.fil | Fil: Thomas, Caroline. Universite de Nantes; Francia | |
| dc.description.fil | Fil: Hühn, Regina. University Hospital Halle; Alemania | |
| dc.description.fil | Fil: Magerus, Aude. Université Paris-Cité, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases; Francia | |
| dc.description.fil | Fil: Lorenz, Myriam. Universitat Ulm; Alemania | |
| dc.description.fil | Fil: Schwarz, Klaus. Universitat Ulm; Alemania | |
| dc.description.fil | Fil: Brieux Olivera, Amelia Carolina Marta. Université Paris-Cité, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases; Francia | |
| dc.description.fil | Fil: Ehl, Stephan. Albert Ludwigs University of Freiburg; Alemania | |
| dc.description.fil | Fil: Rensing Ehl, Anne. Albert Ludwigs University of Freiburg; Alemania | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Maccari, Maria Elena; Schneider, Pascal; Smulski, Cristian Roberto; Meinhardt, Andrea; Pinto, Fernando; et al.; Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations; Mosby-Elsevier; Journal of Allergy and Clinical Immunology; 151; 5; 1-2023; 1391-1401 | es |
| dc.identifier.eissn | 1085-8725 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0091-6749 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/226006 | |
| dc.journal.ciudad | Maryland | es |
| dc.journal.number | 5 | es |
| dc.journal.pagination | 1391-1401 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Journal of Allergy and Clinical Immunology | es |
| dc.journal.volume | 151 | es |
| dc.language.iso | eng | es |
| dc.publisher | Mosby-Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.jacionline.org/article/S0091-6749(23)00001-5/ | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jaci.2022.11.028 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | APOPTOSIS | es |
| dc.subject | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME | es |
| dc.subject | FAS | es |
| dc.subject | FAS LIGAND | es |
| dc.subject | INBORN ERROR OF IMMUNITY | es |
| dc.subject.classification | Inmunología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.2d9af9e3-67eb-4a10-96e1-32ee41cd3443_E.pdf
- Tamaño:
- 2.6 MB
- Formato:
- Adobe Portable Document Format